Starting 1 May 2025 , medicine labels in Australia will begin to phase out dual ingredient names and move towards using only the updated...

The Health Sciences Authority (HSA) is set to roll out a significant update to its regulatory infrastructure with the Singapore Health...

New legislation signed into law by the Medicines and Healthcare products Regulatory Agency (MHRA) on 11 April 2025  marks the start of a...

On the 17th of April 2025, the Drug Regulatory Authority of Pakistan (DRAP) released an update announcing a significant development in...

The Medical Device Authority (MDA) has announced a key regulatory update that impacts all stakeholders within the medical device and...

Starting 1 May 2025 , the Medical Device Authority (MDA) is pleased to announce that all product classification applications must be...

The International Medical Device Regulators Forum (IMDRF) has opened a critical consultation period for its Playbook for Medical Device...

The Department of Health and Family Welfare has taken a crucial step to support small and medium pharmaceutical manufacturers by granting...

The recent adjustment to the “Announcement of the State Drug Administration on Matters Related to the Production of Imported Medical...

The Good Regulatory Practise for New Zealand (GRTPNZ) guidelines for clinical trials state that any modifications to a trial protocol...

To provide clarity and streamline compliance with the Medical Device Act 2012 (Act 737), on the 13 March 2025, the Medical Device...

The increasing integration of technology in healthcare has revolutionized patient care and introduced new cybersecurity challenges. As...